References
- Civin C. I., Strauss I. C., Brovall C., Fackler M. J., Schwartz J. F., Shaper J. H. Antigenic analysis of hematopoiesis: a hematopoietic progenitor cell surface antigen defined by a monoclonal antibody raised against KG-la cells. J. Immunol. 1984; 133: 157–165
- Andrews R. G., Singer J. W., Bernstein I. D. Monoclonal antibody 12.8 recognizes a 115–kd molecule present on both unipotent and multipotent hematopoietic colony-forming cells and their precursors. Blood 1986; 67: 842–845
- Berenson R. J., Bensinger W. I., Kalamasz D. Positive selection of viable cell populations using avidin-biotin immunoadsorption. J. Immunol. Methods 1986; 91: 11–19
- Berenson R. J., Bensinger W. I., Kalamasz D., Schuening F., Deeg H. J., Graham T., Storb R. Engraftment of dogs with Ia-positive marrow cells isolated by avidinbiotin immunoadsorption. Blood 1987; 69: 1363–1367
- Berenson R. J., Andrews R. G., Bensinger W. I., Kalamasz D. F., Hill R. S., Still B. J., Weiden P., Shulman H. M., Warnke R., Buckner C. D., Bernstein I. D. Selection of CD34+ marrow cells for autologous marrow transplantation. Hematopoietic progenitor selection. Autologous Bone Marrow Transplantation. Proceedings of the Fourth International Symposium. 1989, A. Dicke Karel, Gary Spitzer, Sundar Jagannath, Mary Jean Evinger-Hodges. 55–60
- Berenson R. J., Andrews R. G., Bensinger W. I., Kalamasz D., Knitter G., Buckner C. D., Bernstein I. D. Antigen CD34+ marrow cells engraft lethally irradiated baboons. J. Clin. Invest. 1988; 81: 951–955
- Berenson R. I., Bensinger W. I., Hill R. S., Andrews R. G., Garcia-Lopez J., Kalamasz D. F., Still B. J., Spitzer G., Buckner C. D., Bernstein I. D., Thomas E. D. Engraftment after infusion of CD34+ marrow cells in patients with breast cancer or neuroblastoma. Blood 1991; 77: 1717–1722
- Shpall E. J., Jones R. B., Franklin W., Bearman S., Stemmer S., Hami L., Petsche D., Taffs S., Myers S., Purdy M., Heimfeld S., Hallagan J., Berenson R. J. Transplantation of enriched autologous CD34(+) hematopoietic progenitor cells into breast cancer patients following high-dose chemotherapy. Proc. Am. Soc. Clin. Oncol. 1993; 12: 105
- Kernan N. A., Bartsch G., Ash R. C., Beatty P. G., Champlin R., Filipovich A., Gajewski J., Hansen J. A., Henslee-Downey J., McCullough J., McGlave P., Perkins H. A., Phillips G. L., Sanders J., Stroncek D., Thomas E. D., Blume K. G. Analysis of 462 transplantations from unrelated donors facilitated by the National Marrow Donor Program. N. Engl. J. Med. 1993; 328: 693–602
- Cassel A., Cottler-Fox M., Doren S., Dunbar C. E. Retroviral-mediated gene transfer into CD34–enriched human peripheral blood stem cells. Exp. Hematol. 1993; 21: 585–591
- Brugger W., Mocklin W., Heimfeld S., Berenson R. J., Mertelsmann R., Kanz L. Ex vivo expansion of enriched peripheral blood CD34+ progenitor cells by stem cell factor, interleukin-1β, interleukin-6, interleukin-3, interferon-gamma, and erythropoietin. Blood 1993; 81: 2579–2598